Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Obesity × penclomedine × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Unspecified Adult Solid Tumor, Protocol Specific 1 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Polycystic Ovary Syndrome 1 Obesity 1 Lymphoma, Non-Hodgkin 1 Lymphoma, Mantle-Cell 1 Lymphoma, Large-Cell, Immunoblastic 1 Lymphoma, Large-Cell, Anaplastic 1 Lymphoma, Large B-Cell, Diffuse 1 Lymphoma, Follicular 1 Lymphoma, B-Cell, Marginal Zone 1 Lymphoma 1 Leukemia, Lymphocytic, Chronic, B-Cell 1 Immunoblastic Lymphadenopathy 1 Hodgkin Disease 1 Fatty Liver 1 Burkitt Lymphoma 1

Interventions

Exercise 22 Metformin 18 Methods 7 Diet Therapy 7 Diet 7 Tirzepatide 6 Resistance Training 6 Nutrition Assessment 6 Early Intervention, Educational 6 Counseling 6 Caloric Restriction 6 Exenatide 5 Educational Status 4 Docosahexaenoic Acids 4 Diet, Mediterranean 4 semaglutide 3 Vitamin D 3 Therapeutics 3 Standard of Care 3 Liraglutide 3 Dexamethasone 3 Yoga 2 Tablets 2 Surveys and Questionnaires 2 Sugars 2 Specimen Handling 2 Ovidrel 2 Nutritional Status 2 Naltrexone 2 Mindfulness-Based Stress Reduction 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02157974 2024-06-04

APPLE

University of Colorado, Denver

Phase 2/3 Completed

92 enrolled 17 charts

Fatty Liver, Obesity, Polycystic Ovary Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon ⚡